Skip to main content
Erschienen in: Pituitary 2/2018

31.01.2018

Apoplexy in nonfunctioning pituitary adenomas

verfasst von: Luiz Eduardo Wildemberg, Andrea Glezer, Marcello D. Bronstein, Mônica R. Gadelha

Erschienen in: Pituitary | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Pituitary apoplexy is an uncommon event, occurring due to the infarction and/or haemorrhage usually of a previously unknown pituitary adenoma. It can occur in all adenoma subtypes but is more common in nonfunctioning pituitary adenomas. The physiopathology is not completely clear, and precipitating factors, such as major surgeries, anticoagulant use or pituitary dynamic tests, can be found in up to 40% of patients. The clinical presentation is characterized by a rapid onset with a headache as the main symptom, but visual disturbances can also be present as well as meningism and intracranial hypertension. The diagnosis is based on imaging evaluations, mainly using magnetic resonance imaging, which can show various patterns depending on the timeframe following the occurrence of the apoplectic event. Pituitary hormonal deficits are also common, and the evaluation of hormonal levels is mandatory. Pituitary apoplexy can be managed by surgery or conservative treatment, and a multidisciplinary team is essential for the decision-making process. The outcome is usually positive with both surgical and conservative approaches, but surveillance is needed due to the risk of re-bleeding or tumour recurrence.
Literatur
1.
Zurück zum Zitat Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P (2015) Pituitary Apoplexy Endocr Rev 36:622–645PubMed Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P (2015) Pituitary Apoplexy Endocr Rev 36:622–645PubMed
2.
Zurück zum Zitat Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, Markey A, Plant G, Powell M, Sinha S, Wass J (2011) UK guidelines for the management of pituitary apoplexy. Clin Endocrinol 74:9–20CrossRef Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, Markey A, Plant G, Powell M, Sinha S, Wass J (2011) UK guidelines for the management of pituitary apoplexy. Clin Endocrinol 74:9–20CrossRef
3.
Zurück zum Zitat Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol 72:377–382CrossRef Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol 72:377–382CrossRef
4.
Zurück zum Zitat Raappana A, Koivukangas J, Ebeling T, Pirilä T (2010) Incidence of pituitary adenomas in Northern Finland in 1992–2007. J Clin Endocrinol Metab 95:4268–4275CrossRefPubMed Raappana A, Koivukangas J, Ebeling T, Pirilä T (2010) Incidence of pituitary adenomas in Northern Finland in 1992–2007. J Clin Endocrinol Metab 95:4268–4275CrossRefPubMed
5.
Zurück zum Zitat Nomikos P, Ladar C, Fahlbusch R, Buchfelder M (2004) Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas—a study on 721 patients. Acta Neurochir 146:27–35CrossRefPubMed Nomikos P, Ladar C, Fahlbusch R, Buchfelder M (2004) Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas—a study on 721 patients. Acta Neurochir 146:27–35CrossRefPubMed
6.
Zurück zum Zitat Vargas G, Gonzalez B, Ramirez C, Ferreira A, Espinosa E, Mendoza V, Guinto G, Lopez-Felix B, Zepeda E, Mercado M (2015) Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas. Int J Endocrinol 2015:756069CrossRefPubMedPubMedCentral Vargas G, Gonzalez B, Ramirez C, Ferreira A, Espinosa E, Mendoza V, Guinto G, Lopez-Felix B, Zepeda E, Mercado M (2015) Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas. Int J Endocrinol 2015:756069CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Nielsen EH, Lindholm J, Bjerre P, Christiansen JS, Hagen C, Juul S, Jørgensen J, Kruse A, Laurberg P (2006) Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma. Clin Endocrinol 64:319–322CrossRef Nielsen EH, Lindholm J, Bjerre P, Christiansen JS, Hagen C, Juul S, Jørgensen J, Kruse A, Laurberg P (2006) Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma. Clin Endocrinol 64:319–322CrossRef
8.
Zurück zum Zitat Bills DC, Meyer FB, Laws ER, Davis DH, Ebersold MJ, Scheithauer BW, Ilstrup DM, Abboud CF (1993) A retrospective analysis of pituitary apoplexy. Neurosurgery 33:602–608 discussion 608–609CrossRefPubMed Bills DC, Meyer FB, Laws ER, Davis DH, Ebersold MJ, Scheithauer BW, Ilstrup DM, Abboud CF (1993) A retrospective analysis of pituitary apoplexy. Neurosurgery 33:602–608 discussion 608–609CrossRefPubMed
9.
Zurück zum Zitat Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J (1995) Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab 80:2190–2197PubMed Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J (1995) Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab 80:2190–2197PubMed
10.
Zurück zum Zitat Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol 51:181–188CrossRef Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol 51:181–188CrossRef
11.
Zurück zum Zitat Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ (2004) Acute management of pituitary apoplexy–surgery or conservative management? Clin Endocrinol 61:747–752CrossRef Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ (2004) Acute management of pituitary apoplexy–surgery or conservative management? Clin Endocrinol 61:747–752CrossRef
12.
Zurück zum Zitat Sibal L, Ball SG, Connolly V, James RA, Kane P, Kelly WF, Kendall-Taylor P, Mathias D, Perros P, Quinton R, Vaidya B (2004) Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary 7:157–163CrossRefPubMed Sibal L, Ball SG, Connolly V, James RA, Kane P, Kelly WF, Kendall-Taylor P, Mathias D, Perros P, Quinton R, Vaidya B (2004) Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary 7:157–163CrossRefPubMed
13.
Zurück zum Zitat Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, Shimon I (2005) Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir 147:151–157 discussion 157CrossRefPubMed Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, Shimon I (2005) Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir 147:151–157 discussion 157CrossRefPubMed
14.
Zurück zum Zitat Pal A, Capatina C, Tenreiro AP, Guardiola PD, Byrne JV, Cudlip S, Karavitaki N, Wass JA (2011) Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences. Clin Endocrinol 75:501–504CrossRef Pal A, Capatina C, Tenreiro AP, Guardiola PD, Byrne JV, Cudlip S, Karavitaki N, Wass JA (2011) Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences. Clin Endocrinol 75:501–504CrossRef
15.
Zurück zum Zitat Bujawansa S, Thondam SK, Steele C, Cuthbertson DJ, Gilkes CE, Noonan C, Bleaney CW, Macfarlane IA, Javadpour M, Daousi C (2014) Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom. Clin Endocrinol 80:419–424CrossRef Bujawansa S, Thondam SK, Steele C, Cuthbertson DJ, Gilkes CE, Noonan C, Bleaney CW, Macfarlane IA, Javadpour M, Daousi C (2014) Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom. Clin Endocrinol 80:419–424CrossRef
16.
Zurück zum Zitat Jho DH, Biller BM, Agarwalla PK, Swearingen B (2014) Pituitary apoplexy: large surgical series with grading system. World Neurosurg 82:781–790CrossRefPubMed Jho DH, Biller BM, Agarwalla PK, Swearingen B (2014) Pituitary apoplexy: large surgical series with grading system. World Neurosurg 82:781–790CrossRefPubMed
17.
Zurück zum Zitat Vargas G, Gonzalez B, Guinto G, Mendoza V, López-Félix B, Zepeda E, Mercado M (2014) Pituitary apoplexy in nonfunctioning pituitary macroadenomas: a case-control study. Endocr Pract 20:1274–1280PubMed Vargas G, Gonzalez B, Guinto G, Mendoza V, López-Félix B, Zepeda E, Mercado M (2014) Pituitary apoplexy in nonfunctioning pituitary macroadenomas: a case-control study. Endocr Pract 20:1274–1280PubMed
18.
Zurück zum Zitat Singh TD, Valizadeh N, Meyer FB, Atkinson JL, Erickson D, Rabinstein AA (2015) Management and outcomes of pituitary apoplexy. J Neurosurg 122:1450–1457CrossRefPubMed Singh TD, Valizadeh N, Meyer FB, Atkinson JL, Erickson D, Rabinstein AA (2015) Management and outcomes of pituitary apoplexy. J Neurosurg 122:1450–1457CrossRefPubMed
19.
Zurück zum Zitat Giritharan S, Gnanalingham K, Kearney T (2016) Pituitary apoplexy—bespoke patient management allows good clinical outcome. Clin Endocrinol 85:415–422CrossRef Giritharan S, Gnanalingham K, Kearney T (2016) Pituitary apoplexy—bespoke patient management allows good clinical outcome. Clin Endocrinol 85:415–422CrossRef
20.
Zurück zum Zitat Grzywotz A, Kleist B, Möller LC, Hans VH, Göricke S, Sure U, Müller O, Kreitschmann-Andermahr I (2017) Pituitary apoplexy—a single center retrospective study from the neurosurgical perspective and review of the literature. Clin Neurol Neurosurg 163:39–45CrossRefPubMed Grzywotz A, Kleist B, Möller LC, Hans VH, Göricke S, Sure U, Müller O, Kreitschmann-Andermahr I (2017) Pituitary apoplexy—a single center retrospective study from the neurosurgical perspective and review of the literature. Clin Neurol Neurosurg 163:39–45CrossRefPubMed
22.
Zurück zum Zitat Gondim JA, de Albuquerque LAF, Almeida JP, Bulcao T, Gomes E, Schops M, Vasconcelos R, da Paz F, Guimarães SB (2017) Endoscopic endonasal surgery for treatment of pituitary apoplexy: 16 years of experience in a specialized pituitary center: endoscopic surgery for pituitary apoplexy. World Neurosurg. https://doi.org/10.1016/j.wneu.2017.08.131 PubMed Gondim JA, de Albuquerque LAF, Almeida JP, Bulcao T, Gomes E, Schops M, Vasconcelos R, da Paz F, Guimarães SB (2017) Endoscopic endonasal surgery for treatment of pituitary apoplexy: 16 years of experience in a specialized pituitary center: endoscopic surgery for pituitary apoplexy. World Neurosurg. https://​doi.​org/​10.​1016/​j.​wneu.​2017.​08.​131 PubMed
23.
Zurück zum Zitat Dubuisson AS, Beckers A, Stevenaert A (2007) Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg 109:63–70CrossRefPubMed Dubuisson AS, Beckers A, Stevenaert A (2007) Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg 109:63–70CrossRefPubMed
24.
Zurück zum Zitat Fernández-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Pérez L, Ponce de León-Lovatón, PG, Erwin PJ, Carey J, Montori VM (2011) Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab 96:905–912CrossRefPubMed Fernández-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Pérez L, Ponce de León-Lovatón, PG, Erwin PJ, Carey J, Montori VM (2011) Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab 96:905–912CrossRefPubMed
25.
Zurück zum Zitat Sivakumar W, Chamoun R, Nguyen V, Couldwell WT (2011) Incidental pituitary adenomas. Neurosurg Focus 31:E18CrossRefPubMed Sivakumar W, Chamoun R, Nguyen V, Couldwell WT (2011) Incidental pituitary adenomas. Neurosurg Focus 31:E18CrossRefPubMed
26.
Zurück zum Zitat Oldfield EH, Merrill MJ (2015) Apoplexy of pituitary adenomas: the perfect storm. J Neurosurg 122:1444–1449CrossRefPubMed Oldfield EH, Merrill MJ (2015) Apoplexy of pituitary adenomas: the perfect storm. J Neurosurg 122:1444–1449CrossRefPubMed
27.
Zurück zum Zitat Möller-Goede DL, Brändle M, Landau K, Bernays RL, Schmid C (2011) Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol 164:37–43CrossRefPubMed Möller-Goede DL, Brändle M, Landau K, Bernays RL, Schmid C (2011) Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol 164:37–43CrossRefPubMed
28.
Zurück zum Zitat Zhu X, Wang Y, Zhao X, Jiang C, Zhang Q, Jiang W, Chen H, Shou X, Zhao Y, Li Y, Li S, Ye H (2015) Incidence of pituitary apoplexy and its risk factors in chinese people: a database study of patients with pituitary adenoma. PLoS ONE 10:e0139088CrossRefPubMedPubMedCentral Zhu X, Wang Y, Zhao X, Jiang C, Zhang Q, Jiang W, Chen H, Shou X, Zhao Y, Li Y, Li S, Ye H (2015) Incidence of pituitary apoplexy and its risk factors in chinese people: a database study of patients with pituitary adenoma. PLoS ONE 10:e0139088CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Semple PL, Webb MK, de Villiers JC, Laws ER (2005) Pituitary apoplexy. Neurosurgery 56:65–72 (discussion 72–63)CrossRefPubMed Semple PL, Webb MK, de Villiers JC, Laws ER (2005) Pituitary apoplexy. Neurosurgery 56:65–72 (discussion 72–63)CrossRefPubMed
30.
Zurück zum Zitat Briet C, Salenave S, Chanson P (2015) Pituitary apoplexy. Endocrinol Metab Clin North Am 44:199–209CrossRefPubMed Briet C, Salenave S, Chanson P (2015) Pituitary apoplexy. Endocrinol Metab Clin North Am 44:199–209CrossRefPubMed
32.
Zurück zum Zitat Glezer A, Bronstein MD (2015) Pituitary apoplexy: pathophysiology, diagnosis and management. Arch Endocrinol Metab 59:259–264CrossRefPubMed Glezer A, Bronstein MD (2015) Pituitary apoplexy: pathophysiology, diagnosis and management. Arch Endocrinol Metab 59:259–264CrossRefPubMed
33.
Zurück zum Zitat Morsi A, Jamal S, Silverberg JD (1996) Pituitary apoplexy after leuprolide administration for carcinoma of the prostate. Clin Endocrinol 44:121–124CrossRef Morsi A, Jamal S, Silverberg JD (1996) Pituitary apoplexy after leuprolide administration for carcinoma of the prostate. Clin Endocrinol 44:121–124CrossRef
34.
Zurück zum Zitat Wildemberg LE, Neto LV, Niemeyer P, Gasparetto EL, Chimelli L, Gadelha MR (2012) Association of dengue hemorrhagic fever with multiple risk factors for pituitary apoplexy. Endocr Pract 18:e97-e101CrossRefPubMed Wildemberg LE, Neto LV, Niemeyer P, Gasparetto EL, Chimelli L, Gadelha MR (2012) Association of dengue hemorrhagic fever with multiple risk factors for pituitary apoplexy. Endocr Pract 18:e97-e101CrossRefPubMed
35.
Zurück zum Zitat Kumar V, Kataria R, Mehta VS (2011) Dengue hemorrhagic fever: a rare cause of pituitary tumor hemorrhage and reversible vision loss. Indian J Ophthalmol 59:311–312CrossRefPubMedPubMedCentral Kumar V, Kataria R, Mehta VS (2011) Dengue hemorrhagic fever: a rare cause of pituitary tumor hemorrhage and reversible vision loss. Indian J Ophthalmol 59:311–312CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Balarini Lima GA, Machado EeO, Dos Santos Silva CM, Filho PN, Gadelha MR (2008) Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline. Pituitary 11:287–292CrossRefPubMed Balarini Lima GA, Machado EeO, Dos Santos Silva CM, Filho PN, Gadelha MR (2008) Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline. Pituitary 11:287–292CrossRefPubMed
37.
Zurück zum Zitat Pivonello R, Matrone C, Filippella M, Cavallo LM, Di Somma C, Cappabianca P, Colao A, Annunziato L, Lombardi G (2004) Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. J Clin Endocrinol Metab 89:1674–1683CrossRefPubMed Pivonello R, Matrone C, Filippella M, Cavallo LM, Di Somma C, Cappabianca P, Colao A, Annunziato L, Lombardi G (2004) Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. J Clin Endocrinol Metab 89:1674–1683CrossRefPubMed
38.
Zurück zum Zitat Greenman Y, Cooper O, Yaish I, Robenshtok E, Sagiv N, Jonas-Kimchi T, Yuan X, Gertych A, Shimon I, Ram Z, Melmed S, Stern N (2016) Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists. Eur J Endocrinol 175:63–72CrossRefPubMed Greenman Y, Cooper O, Yaish I, Robenshtok E, Sagiv N, Jonas-Kimchi T, Yuan X, Gertych A, Shimon I, Ram Z, Melmed S, Stern N (2016) Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists. Eur J Endocrinol 175:63–72CrossRefPubMed
39.
Zurück zum Zitat Vieira Neto L, Wildemberg LE, Moraes AB, Colli LM, Kasuki L, Marques NV, Gasparetto EL, de Castro M, Takiya CM, Gadelha MR (2015) Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy. Clin Endocrinol 82:739–746CrossRef Vieira Neto L, Wildemberg LE, Moraes AB, Colli LM, Kasuki L, Marques NV, Gasparetto EL, de Castro M, Takiya CM, Gadelha MR (2015) Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy. Clin Endocrinol 82:739–746CrossRef
40.
Zurück zum Zitat Bonneville F, Cattin F, Marsot-Dupuch K, Dormont D, Bonneville JF, Chiras J (2006) T1 signal hyperintensity in the sellar region: spectrum of findings. Radiographics 26:93–113CrossRefPubMed Bonneville F, Cattin F, Marsot-Dupuch K, Dormont D, Bonneville JF, Chiras J (2006) T1 signal hyperintensity in the sellar region: spectrum of findings. Radiographics 26:93–113CrossRefPubMed
41.
42.
Zurück zum Zitat Waqar M, McCreary R, Kearney T, Karabatsou K, Gnanalingham KK (2017) Sphenoid sinus mucosal thickening in the acute phase of pituitary apoplexy. Pituitary 20:441–449CrossRefPubMedPubMedCentral Waqar M, McCreary R, Kearney T, Karabatsou K, Gnanalingham KK (2017) Sphenoid sinus mucosal thickening in the acute phase of pituitary apoplexy. Pituitary 20:441–449CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Semple PL, Jane JA, Lopes MB, Laws ER (2008) Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results. J Neurosurg 108:909–915CrossRefPubMed Semple PL, Jane JA, Lopes MB, Laws ER (2008) Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results. J Neurosurg 108:909–915CrossRefPubMed
44.
Zurück zum Zitat Capatina C, Inder W, Karavitaki N, Wass JA (2015) Management of endocrine disease: pituitary tumour apoplexy. Eur J Endocrinol 172:R179-190CrossRef Capatina C, Inder W, Karavitaki N, Wass JA (2015) Management of endocrine disease: pituitary tumour apoplexy. Eur J Endocrinol 172:R179-190CrossRef
46.
Zurück zum Zitat Abdulbaki A, Kanaan I (2017) The impact of surgical timing on visual outcome in pituitary apoplexy: literature review and case illustration. Surg Neurol Int 8:16CrossRefPubMedPubMedCentral Abdulbaki A, Kanaan I (2017) The impact of surgical timing on visual outcome in pituitary apoplexy: literature review and case illustration. Surg Neurol Int 8:16CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Tu M, Lu Q, Zhu P, Zheng W (2016) Surgical versus non-surgical treatment for pituitary apoplexy: a systematic review and meta-analysis. J Neurol Sci 370:258–262CrossRefPubMed Tu M, Lu Q, Zhu P, Zheng W (2016) Surgical versus non-surgical treatment for pituitary apoplexy: a systematic review and meta-analysis. J Neurol Sci 370:258–262CrossRefPubMed
Metadaten
Titel
Apoplexy in nonfunctioning pituitary adenomas
verfasst von
Luiz Eduardo Wildemberg
Andrea Glezer
Marcello D. Bronstein
Mônica R. Gadelha
Publikationsdatum
31.01.2018
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 2/2018
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-018-0870-x

Weitere Artikel der Ausgabe 2/2018

Pituitary 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.